Transparent Interactions

Working with Healthcare Professionals and Patients

We are committed to transparency. Therefore, we disclose the transfers of value we make to individual healthcare professionals and patients and to their respective organizations. We work with healthcare professionals and patient organizations to deliver new treatment options within brain diseases and our interactions are well-regulated.

Strength in collaboration

To develop and deliver innovative treatment of brain disease, we work with a range of stakeholders. These include healthcare professionals, patients and their respective organizations. We collaborate on research, clinical development, exchange of scientific information, and marketing and sales activities.

 

These interactions are well-regulated by the national laws and industry association regulations that we integrate into our working processes, training and guidance.

 

We are committed to transparency and our disclosed information follows the current laws or regulations from the industry associations we have joined, such as the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Transfers of value to healthcare professionals and patient organizations

Here you can find an overview, together with the locations, of Lundbeck’s interactions with healthcare professionals and the related transfers of value:

Methodological note

EFPIA Disclosure Code Self-Certification

Countries that Disclose

Country Year Links
Austria 2016-2019 Lundbeck Austria Website
PO Sponsorship
Belgium 2015-2019 Industry Association Website
Brazil 2017-2019 Industry Association Website
Bulgaria 2015-2019 Lundbeck Corporate Website
Croatia 2015-2019 Lundbeck Corporate Website
Cyprus 2015-2019 Lundbeck Greece Website
KEFEA
Czech Republic 2015-2019 Industry Association Website
Denmark 2015-2019 Local Authority Website
PO Sponsorships
Estonia 2015-2019 Lundbeck Corporate Website
Finland 2015-2019 Lundbeck Finland Website
France 2015-2019 Ministry of Social Affairs and Health Website
Germany 2016-2019 Lundbeck Germany Website
Greece 2015-2019 Lundbeck Greece Website
Hungary 2015-2019 Lundbeck Corporate Website
Ireland 2015-2019 Industry Association Website
PO Sponsorships
Italy 2016-2019 Lundbeck Italy Website
PO Sponsorships
Japan 2015-2019 Lundbeck Japan Website
Latvia 2015-2017
2016-2019
Industry Association Website
Lundbeck Corporate Website
Lithuania 2015-2019 Lundbeck Corporate Website
Luxembourg 2015-2019 Industry Association Website
Lundbeck Luxembourg Website
Norway 2015-2019 Lundbeck Norway Website
Poland 2015-2019 Lundbeck Poland Website
Portugal 2015-2019 Health Authority Website
Romania 2015-2019 Local Authority Website
Russia 2015-2019 Lundbeck Russia Website
Serbia 2015
2016
Lundbeck Corporate Website
Company closure
Slovakia 2015-2019 Lundbeck Slovakia Website
AIFP
Slovenia 2016-2019 Lundbeck Slovenia Website
Spain 2015-2019 Lundbeck Spain Website
Sweden 2015-2019 Industry Association Website
Switzerland 2015-2019 Lundbeck Switzerland Website
PO Sponsorships
The Netherlands 2016-2019 Industry Association Website
Ukraine 2015-2019 Lundbeck Corporate Website
United Kingdom 2015-2019 Industry Association Website
United States 2015-2019 Federal Government Website

Aggregate disclosures

Lundbeck discloses payments and other transfers for value to HCPs and HCOs in aggregate, if the HCP or HCO has used their legal right to refuse consent to individual disclosure, in accordance with the EFPIA Disclosure Code. The data covers Lundbeck affiliates that use Lundbeck’s corporate website for disclosure. Data from other countries can be found on the Country overview tab.

EFPIA aggregate disclosures on this site include data from the following countries and the tables are organized according to EFPIA specifications:

  Event Sponsorships Consultancies (Fee for Service)
Aggregate HCPs Registration fees Travel & Accomodation Fees Related expenses
Number and % of non-disclosed HCPs 0 4 (3%) 0 0
Amount and % related to non-disclosed HCPs €0 €329 (1%) €0 €0

All Bulgarian HCOs have consented to disclosure.

  Event Sponsorships Consultancies (Fee for Service)
Aggregate HCPs Registration fees Travel & Accomodation Fees Related expenses
Number and % of non-disclosed HCPs 0 0 12 (15%) 0
Amount and % related to non-disclosed HCPs €0 €0 €4,035.05 (13%) €0

All Croatian HCOs have consented to disclosure.

All Estonian HCPs have consented to disclosure.

All Estonian HCOs have consented to disclosure.

  Event Sponsorships Consultancies (Fee for Service)
Aggregate HCPs Registration fees Travel & Accomodation Fees Related expenses
Number and % of non-disclosed HCPs 223 (67%) 108 (71%) 0 0
Amount and % related to non-disclosed HCPs €39,900 (76%) €50,248 (78%) €0 €0
  Event Sponsorships Consultancies (Fee for Service)
Aggregate HCOs Donations & Grants
Sponsorship of HCO Registration fees Travel & Accomm. Fees Related expenses
Number and % of non-disclosed HCOs 0 5 (100%) 0 0 7 (78%) 0
Amount and % related to non-disclosed HCOs €0 €5,134 (100%) €0 €0 €40,090 (88%)  €0

All Latvian HCPs have consented to disclosure.

All Latvian HCOs have consented to disclosure.

  Event Sponsorships Consultancies (Fee for Service)
Aggregate HCPs Registration fees Travel & Accomodation Fees Related expenses
Number and % of non-disclosed HCPs 1 (6%) 4 (11%) 0 0
Amount and % related to non-disclosed HCPs €715 (5%) €2,538 (3%) €0 €0

All Lithuania HCOs have consented to disclosure.

  Event Sponsorships Consultancies (Fee for Service)
Aggregate HCPs Registration fees Travel & Accomodation Fees Related expenses
Number and % of non-disclosed HCPs 7 (58%) 0 7 (20%) 10 (33%)
Amount and % related to non-disclosed HCPs €3,459 (65%) €0 €1,210 (9%)  €16,147 (53%)
  Event Sponsorships Consultancies (Fee for Service)
Aggregate HCOs Donations & Grants
Sponsorship of HCO Registration fees Travel & Accomm. Fees Related expenses
Number and % of non-disclosed HCOs 2 (100%) 0 0 0 0 0
Amount and % related to non-disclosed HCOs €30,641 (100%) €0 €0 €0 €0 €0

Research and development disclosures

Lundbeck undertakes research activities and conducts clinical studies globally. Clinical studies are conducted in accordance with international guidelines and performed by HCPs and HCOs. Our payments and other transfers of value related to pre-clinical, clinical and non-interventional studies are disclosed in aggregate.

 
  R&D payments to HCPs & HCOs
Country 2015 2016 2017 2018
Bulgaria €579,823 €319,234 €661,840 €1,349,624
Croatia 95,822 HRK 303,693 HRK €24,431 €295
Estonia - - €492,586 €235,171
Hungary €8,507 €30,128 €107,946 €52,271
Latvia See country overview €83,105 €199,889 €164,272
Lithuania €403,371 €229,952 €77,033 -
Ukraine €896,803 €359,207 €99,857 €452,015

The amounts cover payments and other transfers of value to HCPs and HCOs related to pre-clinical, clinical and non-interventional studies in the countries where the Lundbeck affiliate uses Lundbeck’s corporate website for disclosure in accordance with the EFPIA Disclosure Code.

 

Data from other countries can be found under countries that disclose.

More from lundbeck

Responsible Business Conduct

We pursue our business purpose guided by several pillars and our Code of Conduct.

Clinical Data Sharing

Our policy for scientific publications and responsible clinical data sharing.

Patients

We see patients as people and are committed to support the person behind.